British drug regulators have advised doctors to limit how many anticholinergic medicines older patients take, after a safety review concluded that the evidence can neither establish nor rule out a link to dementia.
The Medicines and Healthcare products Regulatory Agency issued the guidance following a review by the Commission on Human Medicines. The review examined 17 studies. Every one of them was rated at serious or critical risk of bias.
